The push to simplify medication access for patients just got a $60.0M boost, with PHIL, Inc. announcing new funding. The company focuses on helping patients get their medications quickly, easily, and affordably by partnering with pharmaceutical brands.
Its technology-powered access programs are designed to improve patient outcomes, provider engagement, and brand performance, particularly for specialty-lite and branded retail therapies. PHIL's platform includes solutions like PHIL Core for digital hub and fulfillment, and PHIL Direct for direct-to-patient services, offering real-time data and end-to-end visibility across the entire access journey.
